Therapeutic drug monitoring
Phenytoin levels: a low total result can hide the wrong conclusion
A phenytoin concentration is not self-interpreting. Protein binding, sampling and the clinical picture matter before deciding that a low total concentration means inadequate treatment. Renal disease and low albumin are precisely the settings where the label asks for caution.
Sources checked October 9, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Name the measurement before comparing a range
A total concentration includes bound and unbound drug, while an unbound concentration measures the free fraction. The cited label describes a commonly effective total range of 10 to 20 mcg/mL and an unbound range of 1 to 2 mcg/mL, while acknowledging variation in clinical control. Identify which measurement the laboratory actually reported.
A number without the unit, assay type and sample context is incomplete. A result of 1.5 cannot be interpreted by silently choosing between total and unbound testing. Copying the total reference range onto an unbound result makes a correct measurement appear dangerously low. Always keep the measurement name and unit attached to the result.
Recognize when total concentration can mislead
The label warns that in renal or hepatic disease and hypoalbuminemia, the unbound fraction can be increased. Total concentrations should be interpreted cautiously, and unbound concentrations may be more useful in these populations. A low albumin value changes the meaning of the total result, not merely the appearance of the laboratory report.
A total concentration below the usual range may coexist with adequate or excessive free exposure. Do not label the patient nonadherent, increase the dose or rule out toxicity solely because the total number is low. Recover the symptoms, kidney and liver context, albumin, medication history and available unbound result.
Use timing and symptoms together
The cited label distinguishes trough samples, which help assess clinically effective levels and adherence, from peak samples, which can help identify an individual's threshold for dose-related adverse effects. Ask when the specimen was obtained relative to actual doses. A random result is not automatically a documented trough.
Possible neurologic toxicity findings require clinical assessment even if the total concentration looks reassuring. Similarly, breakthrough seizures cannot be assigned a cause from a concentration alone. A strong answer integrates the concentration with actual dosing, symptoms and sampling rather than treating the laboratory range as a substitute for the patient.
Do not turn a binding question into blind dose arithmetic
The label notes saturable metabolism, so small dose increments can cause substantial concentration increases in some circumstances. That makes an unsupported increase especially risky when the initial interpretation is already uncertain. This lesson does not supply a dose-adjustment formula or authorize a patient-specific dose change.
An original case may explicitly provide a measured unbound concentration. Use that evidence before inventing a corrected total estimate. If an estimate is used elsewhere, it is still an estimate with assumptions, not a measured free concentration. Requesting or reviewing the appropriate measurement can be the better next step when binding is abnormal.
A worked case
A patient with kidney disease and albumin 2.0 g/dL has a total phenytoin concentration of 7 mcg/mL, measured unbound concentration 2.6 mcg/mL and new gait instability. A colleague proposes increasing the dose because total concentration is below 10. Which interpretation is better supported?
- Identify the binding-risk setting and keep total and unbound values separate.
- The measured unbound value is above the cited usual 1 to 2 mcg/mL range, while symptoms need clinical review.
- Do not endorse a dose increase based only on the low total value; check timing and the full assessment.
Answer: The low total result does not establish underexposure. The measured free concentration and symptoms make the proposed automatic increase unsafe.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Is 1.5 mcg/mL necessarily a low phenytoin level?
No. If it is an unbound result, it falls within the cited usual unbound range.
2. Does low albumin make the total result more self-sufficient?
No. It is a reason to interpret total concentration cautiously.
3. Can a measured unbound concentration be ignored in favor of a total correction estimate?
No. The measured result and clinical context deserve direct assessment.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.